Total Raised

$81.47M

Investors Count

9

Deal Terms

3

Funding, Valuation & Revenue

9 Fundings

EnteroMedics has raised $81.47M over 9 rounds.

EnteroMedics's latest funding round was a IPO for $40M on November 14, 2007.

EnteroMedics's latest post-money valuation is from November 2007.

Sign up for a free demo to see EnteroMedics's valuations in November 2007 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/14/2007

IPO

$40M

$XXM

0

FY undefined

2

10/5/2007

Unattributed VC - VI

$XXM

$XXM

0

FY undefined

0

12/21/2006

Unattributed VC - V

$XXM

$XXM

0

FY undefined

0

12/22/2005

Unattributed VC - IV

$XXM

$XXM

0

FY undefined

0

12/14/2005

Series B

$XXM

$XXM

0

FY undefined

0

Date

11/14/2007

10/5/2007

12/21/2006

12/22/2005

12/14/2005

Round

IPO

Unattributed VC - VI

Unattributed VC - V

Unattributed VC - IV

Series B

Amount

$40M

$XXM

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

2

0

0

0

0

Start free trial
New call-to-action

EnteroMedics Deal Terms

3 Deal Terms

EnteroMedics's deal structure is available for 3 funding rounds, including their IPO from November 14, 2007.

Round

IPO

Unattributed VC - V

Series B

Funding Date

$XXM

$XXM

$XXM

Pre-Money Valuation

$XXM

$XXM

Post-Money Valuation

$XXM

$XXM

Amount Raised

$XXM

$XXM

$XXM

Shares Authorized

Issuance Price

$XXM

Dividend Rate

$XXM

Liquidation Preferences

$XXM

Liquidation Price

Participation

Conversion Price

Anti Dilution

$XXM

General Voting

$XXM

$XXM

$XXM

Board Voting

$XXM

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

IPO

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Unattributed VC - V

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series B

$XXM

$XXM

$XXM

$XXM

EnteroMedics Investors

9 Investors

EnteroMedics has 9 investors. Western Technology Investment invested in EnteroMedics's Unattributed VC - VI funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

9/23/2005

10/5/2007

2
Unattributed VC - III, Unattributed VC - VI (2007)

Debt & Specialty Finance

California

00/00/0000

00/00/0000

MPM BioImpact

Subscribe to see more

Venture Capital

Massachusetts

00/00/0000

00/00/0000

Charter Venture Capital

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Aberdare Ventures

Subscribe to see more

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Bay City Capital

Subscribe to see more

Venture Capital

California

First funding

9/23/2005

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

10/5/2007

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

MPM BioImpact

Charter Venture Capital

Aberdare Ventures

Bay City Capital

Rounds

2
Unattributed VC - III, Unattributed VC - VI (2007)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Debt & Specialty Finance

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Location

California

Massachusetts

California

California

California

EnteroMedics Acquisitions

2 Acquisitions

EnteroMedics acquired 2 companies. Their latest acquisition was ReShape Medical on October 03, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/3/2017

Debt

$XXM

$110.07M

Acquired

2

5/23/2017

Subscribe to see more

$XXM

Subscribe to see more

10

Date

10/3/2017

5/23/2017

Investment Stage

Debt

Companies

Subscribe to see more

Valuation

$XXM

$XXM

Total Funding

$110.07M

Note

Acquired

Subscribe to see more

Sources

2

10

New call-to-action

Compare EnteroMedics to Competitors

Beta-O2 Technologies Logo
Beta-O2 Technologies

Beta-O2 Technologies is a biomedical company that focuses on developing a proprietary implantable bioartificial pancreas for the treatment and potential cure of type 1 diabetes. The company's main product, the ßAir device, contains living cells that sense glucose levels and produce insulin and glucagon, aiming to maintain glycemic control without the need for insulin injections or glucose monitoring. The device is designed to provide immune-isolation of the implanted cells, which may eliminate the need for immunosuppressive therapy. It was founded in 1999 and is based in Rosh HaAyin, Israel.

P
Portaero

Portaero, in stealth mode, is a medical devices firm, developing a device for the treatment of COPD (Chronic obstructive pulmonary disease).

N
NDO Surgical

Medical devices for the treatment of severe gastrointestinal disorders

Mobius Therapeutics Logo
Mobius Therapeutics

Mobius Therapeutics specializes in the development and manufacturing of perioperative pharmaceuticals for the ophthalmology sector. The company offers FDA approved products that improve the preparation and delivery of mitomycin-c in surgeries, catering to the specific needs of the operating room. It is based in St. Louis, Missouri.

LinguaFlex Logo
LinguaFlex

LinguaFlex is a medical device company focused on developing innovative technology for the treatment of obstructive sleep apnea. Their main offering is a patent-pending, minimally invasive device designed to prevent airway blockage by the tongue during sleep, which is currently under clinical investigation. The device is targeted towards individuals with moderate-to-severe obstructive sleep apnea who are seeking alternatives to traditional CPAP machines. It is based in Weston, Florida.

Accord BioMaterials Logo
Accord BioMaterials

Accord BioMaterials specializes in home improvement and renovation products across various sectors including heating, cooling, and air quality management. The company offers a wide range of products such as heaters, air conditioners, humidifiers, air purifiers, and materials for home renovation and safety. These products cater to the needs of homeowners looking to enhance their living spaces with functional and aesthetic improvements. It was founded in 2008 and is based in Ann Arbor, Michigan.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.